| Style | Citing Format |
|---|---|
| MLA | Esfahani MF, Bruck W, Weber MS. "Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?." JAMA Neurology, vol. 72, no. 12, 2015, pp. 1407-1408. |
| APA | Esfahani MF, Bruck W, Weber MS (2015). Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?. JAMA Neurology, 72(12), 1407-1408. |
| Chicago | Esfahani MF, Bruck W, Weber MS. "Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?." JAMA Neurology 72, no. 12 (2015): 1407-1408. |
| Harvard | Esfahani MF, Bruck W, Weber MS (2015) 'Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?', JAMA Neurology, 72(12), pp. 1407-1408. |
| Vancouver | Esfahani MF, Bruck W, Weber MS. Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?. JAMA Neurology. 2015;72(12):1407-1408. |
| BibTex | @article{ author = {Esfahani MF and Bruck W and Weber MS}, title = {Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option?}, journal = {JAMA Neurology}, volume = {72}, number = {12}, pages = {1407-1408}, year = {2015} } |
| RIS | TY - JOUR AU - Esfahani MF AU - Bruck W AU - Weber MS TI - Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-Cd20 a Therapeutic Option? JO - JAMA Neurology VL - 72 IS - 12 SP - 1407 EP - 1408 PY - 2015 ER - |